Clinical Trial Results:
A 12-week treatment, multi-center, randomized, double-blind, double-dummy, parallel-group study to assess the efficacy, safety and tolerability of QVA149 compared to fluticasone/salmeterol in COPD patients with moderate to severe airflow limitation
Summary
|
|
EudraCT number |
2012-005102-22 |
Trial protocol |
BE CZ |
Global completion date |
02 Jul 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v2(current) |
This version publication date |
03 Dec 2019
|
First version publication date |
01 Nov 2019
|
Other versions |
v1 |
Version creation reason |
|
Summary report(s) |
cancellation letter for CQVM149A2328 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.